MedTrace Logo

Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD

NCT05852197 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2023-05-10

No results posted yet for this study

Summary

Patients with PAD were grouped according to the combination of different anticoagulant and antiplate drugs. The type, dosage and duration of anticoagulant and antiplatelet drugs were recorded after operation. Major Adverse Cardiovascular Events and Major Adverse Limb Events were followed up at 1 month, 6 months and 12 months, respectively.

Conditions

  • Anticoagulant Drugs
  • Antiplatelet Drug
  • Peripheral Arterial Disease

Interventions

DRUG

anticoagulant or antiplatelet drugs

combination of anticoagulant or antiplatelet drugs

Sponsors & Collaborators

  • First Affiliated Hospital of Zhejiang University

    lead OTHER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-02-01
Completion
2026-01-01
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05852197 on ClinicalTrials.gov